Future Growth of Cancer Pain Management Market Forecast to 2025 in a Newly Released Report Profiling Mallinckrodt Pharmaceuticals, Pfizer Inc., Teva Pharmaceuticals, Johnson & Johnson Inc., BioDelivery Sciences, Prostrakan Group, Sanofi S.A.

The Global Cancer Pain Management Market Size is gaining traction owning to the factors such as ongoing research and development for developing new drugs, and rising number of patients suffering from cancer.

National Cancer Institute estimates approximately 5,80,350 Americans die from cancer. Cancer is the second leading cause of mortality in the U.S. which accounts for 1 in every 4 deaths. Pain is one of the most apprehended symptoms in cancer. Despite greater availability of pain medications, it is often under-treated in the cancer patients. The pain observed due to growing tumour that destroys nearby tissues, press nerves, bones and organs. In some cases, the tumours cause pain as they release chemicals which harm the internal body parts. Cancer pain is a temporarily changing symptom that involves inflammatory, neuropathic, compression, and ischemic mechanisms. Cancer pain is categorized as chronic and acute pain which is distinct onset, and has prolonged effect. Chronic pain is also characterised by pain flares which is also termed as breakthrough pain.

Request sample copy of this report @ https://www.polarismarketresearch.com/industry-analysis/global-cancer-pain-management-market/request-for-free-sample

Moreover, cancer pain is caused due to various cancer treatments procedures such as Surgical Pain, Phantom Pain, Procedure and Testing, and chemotherapy & radiation treatment. Cancer pain can be controlled by various pain relievers, like opioid, anti-inflammatory drugs, antidepressant, anti-seizers drugs and steroids.

Increasing launch of new drug development as a novel treatment of cancer pain will drive growth in the cancer pain management market.

The cancer pain management market is primarily driven by rising prevalence of cancer worldwide. According to WHO, cancer is the second leading cause of death in North America, and was responsible for 8.8 million deaths in 2015. Additionally, National Cancer Institute estimated 1,685,210 new cases in the U.S. suffering from cancer in 2016. Similarly, various ongoing technological advancements for reducing pain caused due to surgical process would also influence the growth of this market. Moreover, the easy availability of the drugs that are used as painkiller would also propel the cancer pain management market.

Global Cancer Pain Management Market Taxonomy
The cancer pain management market is segmented on the basis of pain, drugs, route, treatment, and geography.

Request For customization @ https://www.polarismarketresearch.com/industry-analysis/global-cancer-pain-management-market/request-for-customization

On the basis of pain type, global cancer pain management market size is segmented as;

• Acute Pain
• Chronic Pain
On the basis of drug type, global cancer pain management market share is segmented as;
• Opioid
• Non-steroidal anti-inflammatory drug
• Aspirin
• Corticosteroids
• Anti-depressants
On the basis of application type, global cancer pain management market size is segmented as;
• Immunotherapy
• Chemotherapy
• Radiotherapy
• Home Therapy
On the basis of end use type, global cancer pain management market share is segmented as;
• Hospitals
• Cancer Care Clinics
• Others

Geographically, the global cancer pain management market size is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

High number of leading manufacturers in North America to boost cancer pain management market in this region.

On the basis of geography, North America is expected to dominate the global cancer pain management market share over forecast period. The primary factors influencing growth of cancer pain management market in this region are continuous efforts for new product development by the manufacturers, high number of patients suffering for cancer, and enhanced healthcare expenditure by the individuals and the government. While, Europe holds the second largest share in cancer pain management market owing to improved medical infrastructure for treating cancer pain. Also, there is a rising trend of consolidation between manufacturers for tapping this growing market.

Browse Complete Report Details @ https://www.polarismarketresearch.com/industry-analysis/global-cancer-pain-management-market/

Key players in the global cancer pain management market are:

• Pfizer Inc.
• Mallinckrodt Pharmaceuticals
• Teva Pharmaceuticals
• Johnson & Johnson Inc.
• Endo Pharmaceuticals
• Eli Lilly & Company
• BioDelivery Sciences
• Prostrakan Group
• Sanofi S.A.
• Meda Pharmaceuticals
• Grunenthal Group
• Daiichi Sankyo.

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.

Contact us-

Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.